MIRA INFORM REPORT

 

 

Report Date :

09.06.2014

 

IDENTIFICATION DETAILS

 

Name :

SANCE LABORATORIES PRIVATE LIMITED

 

 

Registered Office :

VI / 51B, Elappunkal Jn., Kozhuvvanal P.O. Pala, Kottayam-686573, Kerala

 

 

Country :

India

 

 

Financials (as on) :

31.03.2013

 

 

Date of Incorporation :

20.09.2001

 

 

Com. Reg. No.:

09-014957

 

 

Capital Investment / Paid-up Capital :

Rs. 39.600 Millions

 

 

CIN No.:

[Company Identification No.]

U24231KL2001PTC014957

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

TVDS01165D

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer and Exporter a wide
spectrum of Pharmaceutical Products including Capsules, Dry Syrups, Tablets and Dry Powder Injections.

 

 

No. of Employees :

100 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B (28)

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Maximum Credit Limit :

USD 10000

 

 

Status :

Moderate

 

 

Payment Behaviour :

Slow But Correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having moderate track record.

 

The rating is constrained on account of company’s moderate financial risk profile marked by huge accumulated losses incurred by the company.

 

However, trade relations are fair. Business is active. Payment terms are slow but correct.

 

The company can be considered for business dealing with some caution.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31, 2014

 

Country Name

Previous Rating

(31.12.2013)

Current Rating

(31.03.2014)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INDIAN ECONOMIC OVERVIEW

 

US investment bank Goldman Sachs  has upgraded its outlook on Indian markets as it expects positive impact of the election cycle.

 

India’s economy may grow 4.7 % in the current financial year, lower than the official estimate of 4.9 %, Fitch Rating said. The global rating agency expects the economy to pick up in the next two financial years.

 

Global ratings agency Standard & Poor said increasing focus by India Inc on lowering debt is likely to improve their credit profiles.

 

Singapore (1.1 million Indian tourists in 2012), Thailand (one million), the United Arab Emirates ().98 million) and Malaysia ().82 million) emerged as the preferred holidays hotspots for Indians. The total figure is expected to increase to 1.93 million by 2017, according to the latest Eurmonitor international report.

 

There is a $29.34 bn outward foreign direct investment by domestic companies between April and January of 2013/14 which has seen some signs of recovery according to a Care Ratings report.

 

There are 264 number of new companies being set up every day on average during 2014. Most of them are registered in Mumbai. India had 1.38 million registered companies at the end of January, 2014.

 

Twitter like messaging service Weibo Corporation has filed to raise $ 500 million via a US initial public offering. Alibaba, which owns a stake in Weibo is expected to raise about $ 15 billion New York this year in the highest profile Internet IPO since Facebook’s in 2012.

 

Bharti Airtel has raised Rs.2,453.2 crore (350 million Swiss Francs) by selling six-year bonds at a coupon rate of three per cent and maturing in 2020. This is the largest ever bond offering by an Indian company in Swiss Francs. Bharat Petroleum Corporation raised 175 million Swiss Francs by selling five year bonds at 2.98 % coupon rate in February.

 

Indian Oil Corporation plans to invest Rs 7650 crore in setting up a petrochemical complex at its almost complete Paradip refinery in Odhisha in three to four years. The company board is set to consider the setting up of a 700000 tonne per annum polypropylene plant at an estimated cost at Rs.3150 crore.

 

Global chief information officers at gathering in Bangalore in April to meet Indian startups at an event called Tech50 Watchout for Little Eye Labs-Facebook type deals in the making.

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

 

INFORMATION PARTED BY

 

Name :

Ms. Binta Joby

Designation :

Assistant Finance Manager

Contact No.:

91-9446490717

Date :

09.06.2014

 

 

LOCATIONS

 

Registered Office / Factory  :

VI / 51B, Elappunkal Jn., Kozhuvvanal P.O. Pala, Kottayam-686573, Kerala, India

Tel. No.:

91-4822-268877, 267799

Mobile No.:

91-9446490717 (Ms. Binta Joby)

Fax No.:

91-4822-269406

E-Mail :

info@sancepharma.com

Website :

www.sancepharma.com

Location :

Owned

 

 

DIRECTORS

 

AS ON 20.09.2013

 

Name :

Mr. Manoj Joseph

Designation :

Managing Director

Address :

House No.15/ 173, Manhushas Thannipara House, Palai – 686 575, Kerala, India

Date of Birth/Age :

25.05.1965

Date of Appointment :

20.09.2001

DIN No.:

01203664

 

Other Directorship:

 

S. No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Company/ LLP Status

Defaulting status

1

U24231KL2001PTC014916

SANCE PARENTERALS PRIVATE LIMITED

Director

03/09/2001

03/09/2001

Active

NO

2

U24231KL2001PTC014957

SANCE LABORATORIES PRIVATE LIMITED

Managing director

20/09/2001

20/09/2001

Active

NO

3

U52311KL2005PTC017869

MEGASYS BIOTEK PRIVATE LIMITED

Director

02/03/2009

02/03/2009

Active

NO

4

U24232KL2013PTC033239

HAOMA HEALTH CARE PRIVATE LIMITED

Director

04/02/2013

04/02/2013

Active

NO

 

 

Name :

Mrs. Valsamma Joseph

Designation :

Director

Address :

House No.15/ 173, Manhushas Thannipara House, Palai – 686 575, Kerala, India

Date of Birth/Age :

10.01.1946

Date of Appointment :

20.09.2001

DIN No.:

01209952

 

Other Directorship:

 

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Company/ LLP Status

Defaulting status

1

U24231KL2001PTC014957

SANCE LABORATORIES PRIVATE LIMITED

Director

20/09/2001

20/09/2001

Active

NO

2

U24231KL2001PTC014916

SANCE PARENTERALS PRIVATE LIMITED

Managing director

30/09/2001

30/09/2001

Active

NO

 

 

Name :

Mr. Paul Thomas

Designation :

Director

Address :

Puthenpurayil House, Memury P.O. Kottayam Memury P.O. Kottayam – 686 617, Kerala, India

Date of Birth/Age :

08.09.1937

Date of Appointment :

20.09.2001

DIN No.:

01208952

 

Other Directorship:

 

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Company/ LLP Status

Defaulting status

1

U24231KL2001PTC014916

SANCE PARENTERALS PRIVATE LIMITED

Director

03/09/2001

03/09/2001

Active

NO

2

U24231KL2001PTC014957

SANCE LABORATORIES PRIVATE LIMITED

Director

20/09/2001

20/09/2001

Active

NO

 

 

Name :

Dr. Jatin Joseph

Designation :

Director

Address :

House No.15/ 173, Manhushas Thannipara House, Palai – 686 575, Kerala, India

Date of Birth/Age :

23.11.1968

Date of Appointment :

20.09.2001

DIN No.:

05162520

 

 

KEY EXECUTIVES

 

Name :

Ms. Binta Joby

Designation :

Assistant Finance Manager

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

NOTE: Shareholders details are not available

 

AS ON 20.09.2013

 

Equity Shares Break Up

Percentage of Holding

Directors or relatives of Directors

100.00

TOTAL

100.00

 

 

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer and Exporter a wide
spectrum of Pharmaceutical Products including Capsules, Dry Syrups, Tablets and Dry Powder Injections.

 

 

Products :

  • Capsules
  • Dry Syrups
  • Tablets
  • Dry Powder Injections

 

 

Exports :

 

Products :

Finished Goods

Countries :

  • Sri Lanka
  • Thailand
  • China
  • Vietnam
  • Nigeria
  • Africa

 

 

Terms :

 

Selling :

L/C, Credit

 

 

Purchasing :

L/C, Credit

 

PRODUCTION STATUS (AS ON : 31.03.2013)

 

Particulars

Unit

Installed Capacity

Actual Production

Tablets

Nos.

1050

91.77

Capsule

Nos.

450

98.68

Injections

No of Vials

90

45.81

Dry Syrups

Sachet

60

13.47

Dry Syrups

No. of Bottles

22.44

6.72

TOTAL

 

 

256.45

 

 

GENERAL INFORMATION

 

Customers :

End Users

 

  • Ageis Limited
  • Vexta Laboratories Private Limited

 

 

No. of Employees :

100 (Approximately)

 

 

Bankers :

  • Canara Bank, 16/3, F.K.C. Sebastian Buildings, Lalan Bridge Junction Pala-Eratthupetta Road, Pala – 686 575, Kerala, India
  • Axis Bank, Pala
  • State Bank of Travancore
  • South Indian Bank

 

 

Facilities :

Secured Loan

 

Rs. In Millions

31.03.2013

Rs. In Millions

31.03.2012

Long Term Borrowings

 

 

Term Loan

 

 

Term Loan from Canara Bank (Secured by hypothecation of land and building, Plant and Machinery and collateral security of directors)

0.000

18.779

Loan Canara Bank (Car)

0.554

0.799

741FCLR112360001

37.347

52.339

 

 

 

TOTAL

37.901

71.917

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

N. Unnikrishnan and Associates

Chartered Accountants

Address :

25, Carmel Building, Banerji Road, Kochi – 682 018, Kerala, India

PAN No.:

AABPU8342A

 

 

CAPITAL STRUCTURE

 

AS ON 31.03.2013

 

Authorised Capital :

 

No. of Shares

Type

Value

Amount

 

 

 

 

4000000

Equity Shares

Rs.10/- each

Rs. 40.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

 

No. of Shares

Type

Value

Amount

 

 

 

 

3959997

Equity Shares

Rs.10/- each

Rs. 39.600 Millions

 

 

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

31.03.2013

31.03.2012

31.03.2011

 

 

 

 

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

39.600

39.600

39.600

(b) Reserves & Surplus

(37.005)

(68.118)

(87.094)

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

2.595

(28.518)

(47.494)

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

60.065

104.394

101.402

(b) Deferred tax liabilities (Net)

0.000

0.000

0.000

(c) Other long term liabilities

0.000

0.000

0.000

(d) long-term provisions

0.000

0.000

0.268

Total Non-current Liabilities (3)

60.065

104.394

101.670

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

58.357

53.970

48.439

(b) Trade payables

53.893

60.132

25.954

(c) Other current liabilities

10.120

6.246

10.835

(d) Short-term provisions

0.006

0.000

0.000

Total Current Liabilities (4)

122.376

120.348

85.228

 

 

 

 

TOTAL

185.036

196.224

139.404

 

 

 

 

II.          ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

75.942

83.058

84.729

(ii) Intangible Assets

0.000

0.000

0.000

(iii) Capital work-in-progress

0.000

0.000

0.000

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

0.000

0.000

0.000

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d)  Long-term Loan and Advances

0.000

0.000

0.000

(e) Other Non-current assets

0.000

0.000

0.000

Total Non-Current Assets

75.942

83.058

84.729

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

3.260

1.347

0.867

(b) Inventories

51.514

53.072

25.805

(c) Trade receivables

25.742

33.701

14.961

(d) Cash and cash equivalents

2.895

1.643

0.591

(e) Short-term loans and advances

4.250

3.850

3.120

(f) Other current assets

21.433

19.553

9.331

Total Current Assets

109.094

113.166

54.675

 

 

 

 

TOTAL

185.036

196.224

139.404

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2013

31.03.2012

31.03.2011

 

SALES

 

 

 

 

Income

234.978

230.326

130.198

 

Other Income

 

 

 

 

TOTAL

234.978

230.326

130.198

 

 

 

 

 

Less

EXPENSES

 

 

 

 

Cost of Goods Sold

NA

NA

NA

 

Manufacturing Expenses

 

 

 

 

Marketing and Service Expenses

 

 

 

 

TOTAL

NA

NA

NA

 

 

 

 

 

 

NET PROFIT

31.118

18.489

(2.341)

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

F.O.B. Value of Exports

154.967

118.578

66.183

 

TOTAL EARNINGS

154.967

118.578

66.183

 

 

 

 

 

 

IMPORTS

 

 

 

 

Raw Materials

13.763

13.763

NA

 

TOTAL IMPORTS

13.763

13.763

NA

 

 

 

 

 

 

Earnings / (Loss) Per Share (Rs.)

-- 

--

--

 

 

 

KEY RATIOS

 

PARTICULARS

 

31.03.2013

31.03.2012

31.03.2011

Debt Equity Ratio
(Total Debt /Networth)

 

45.63

-5.55

-3.15

 

 

 

 

 

Current Ratio
(Current Asset/Current Liability)

 

0.89

0.94

0.64

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Millions]

 

DEBT EQUITY RATIO

 

Particular

31.03.2011

31.03.2012

31.03.2013

 

(INR in Mlns.)

(INR in Mlns.)

(INR in Mlns.)

Share Capital

39.600

39.600

39.600

Reserves & Surplus

(87.094)

(68.118)

(37.005)

Net worth

(47.494)

(28.518)

2.595

 

 

 

 

long-term borrowings

101.402

104.394

60.065

Short term borrowings

48.439

53.970

58.357

Total borrowings

149.841

158.364

118.422

Debt/Equity ratio

(3.155)

(5.553)

45.635

 

 

YEAR ON YEAR GROWTH

 

Year on Year Growth

31.03.2011

31.03.2012

31.03.2013

 

(INR in Mlns)

(INR in Mlns)

(INR in Mlns)

Total Income 

130.198

230.326

234.978

 

 

76.904

2.020

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2011

31.03.2012

31.03.2013

 

(INR)

(INR)

(INR)

Total Income

130.198

230.326

234.978

Net Profit

(2.341)

18.489

31.118

 

(1.80)%

8.03%

13.24%

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

Yes

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

-----

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

No

17]

Major suppliers

No

18]

Major customers

Yes

19]

Payments terms

Yes

20]

Export / Import details (if applicable)

Yes

21]

Market information

-----

22]

Litigations that the firm / promoter involved in

-----

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

-----

26]

Buyer visit details

-----

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

 

Unsecured Loan

 

Rs. In Millions

31.03.2013

Rs. In Millions

31.03.2012

Long Term Borrowings

 

 

Loan FROM Directors and Shareholders

22.164

32.477

 

 

 

TOTAL

22.164

32.477

 

 

INDEX OF CHARGES

 

S. No

Charge ID

Date of Charge Creation /Modification

Charge amount secured

Charge Holder

Address

Service Request Number (SRN

1

90019246

16/04/2014 *

129,490,000.00

Canara Bank

Arunapuram Branch, FKC Sebastian Buildings, Lalam Bridge Junction, Pala - Erattupetta Road, Pala, Kerala - 686575, India

C03590411

* Date of charge modification

 

NOTE

 

Registered office has been shifted from 15/173, Manjushaspalai P O Kottayam-686575, Kerala, India to the present address w.e.f. 23.01.2014.

 

 

FINANCIAL RESULTS

 

For the year, the company has earned Net Profit of Rs. 31.118 Millions on total income of Rs. 234.978 Millions against a net profit of Rs. 18.489 Millions on total income of Rs. 230.326 Millions in the previous year. The Cash Profit of the year is Rs. 41.770 Millions against Rs. 29.460 Millions in the previous year. The above income includes revenue derived from production under Loan Licenseas and third party manufacturing from reputed Manufacturers.

 

 

FIXED ASSETS

 

  • Land and Land Development
  • Buildings
  • Furniture and Fittings
  • Plant and Machinery
  • Electrical Fittings
  • Production Machineries
  • Utility Machineries
  • Vehicles
  • Computer and Accessories
  • Office Equipments
  • Books
  • Tools
  • Plant and Machinery – Insulation
  • Blister Packing Machine

 

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                                       None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs. 59.19

UK Pound

1

Rs. 99.51

Euro

1

Rs. 80.83

 

 

INFORMATION DETAILS

 

Information Gathered by :

PLK

 

 

Analysis Done by :

KRN

 

 

Report Prepared by :

DPT


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

3

PAID-UP CAPITAL

1~10

3

OPERATING SCALE

1~10

3

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

3

--PROFITABILIRY

1~10

4

--LIQUIDITY

1~10

3

--LEVERAGE

1~10

3

--RESERVES

1~10

3

--CREDIT LINES

1~10

3

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

28

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.